The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-{2-[(4R,6S)-8-Chloro-6-(2,3-dimethoxy-phenyl)-1-isopropyl-4H,6H-2,5-dioxa-3-aza-benzo[e]azulen-4-yl]-acetyl}-piperidine-4-carboxylic acid ID: ALA1778343
PubChem CID: 53354784
Max Phase: Preclinical
Molecular Formula: C30H33ClN2O7
Molecular Weight: 569.05
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(C(=O)O)CC3)c3noc(C(C)C)c3-c3ccc(Cl)cc32)c1OC
Standard InChI: InChI=1S/C30H33ClN2O7/c1-16(2)27-25-19-9-8-18(31)14-21(19)28(20-6-5-7-22(37-3)29(20)38-4)39-23(26(25)32-40-27)15-24(34)33-12-10-17(11-13-33)30(35)36/h5-9,14,16-17,23,28H,10-13,15H2,1-4H3,(H,35,36)/t23-,28-/m1/s1
Standard InChI Key: HSHHDCPKQVEASM-QDPGVEIFSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
14.4155 -7.6641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4143 -8.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0943 -8.8436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0925 -7.2715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6025 -8.0339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1998 -7.2811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4027 -7.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7779 -8.4532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7729 -7.6607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4558 -8.0060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8583 -7.2531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7115 -7.2251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4074 -6.5280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2582 -8.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4556 -8.9839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3896 -9.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1515 -10.1232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6881 -9.4967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6855 -10.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9611 -9.8415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7059 -11.0611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7358 -7.2720 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.2022 -6.3918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7605 -5.8390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5604 -5.0811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8023 -4.8749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2446 -5.4326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4477 -6.1884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5175 -6.0453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0747 -5.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1172 -4.5283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8744 -4.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1603 -7.9514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0099 -7.9257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4165 -7.1744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9668 -6.4475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1107 -6.4717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2702 -7.1497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7185 -7.8768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6757 -6.3979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16 19 1 0
8 9 1 0
19 20 1 0
9 7 1 0
19 21 1 0
4 1 1 0
1 22 1 0
5 10 1 6
23 24 2 0
10 11 1 0
24 25 1 0
2 3 1 0
25 26 2 0
11 12 1 0
26 27 1 0
3 8 2 0
27 28 2 0
28 23 1 0
7 23 1 1
11 13 2 0
24 29 1 0
14 15 1 0
29 30 1 0
1 2 2 0
25 31 1 0
9 4 2 0
31 32 1 0
12 33 1 0
5 6 1 0
6 7 1 0
5 14 1 0
15 16 2 0
16 17 1 0
12 37 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
17 18 1 0
35 38 1 0
18 14 2 0
38 39 1 0
15 8 1 0
38 40 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 569.05Molecular Weight (Monoisotopic): 568.1976AlogP: 6.01#Rotatable Bonds: 7Polar Surface Area: 111.33Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.90CX Basic pKa: ┄CX LogP: 4.49CX LogD: 1.28Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.37Np Likeness Score: -0.44
References 1. Griebenow N, Buchmueller A, Kolkhof P, Schamberger J, Bischoff H.. (2011) Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors., 21 (12): [PMID:21576018 ] [10.1016/j.bmcl.2011.04.092 ] 2. Soltis, D A DA and 9 more authors. 1995-02-01 Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems. [PMID:7864626 ] 3. Cammerer, Simon B SB and 14 more authors. 2007-11 Quinuclidine derivatives as potential antiparasitics. [PMID:17709461 ] 4. Song, Yongcheng and 11 more authors. 2009-02-26 Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. [PMID:19191557 ] 5. Lin, Fu-Yang and 7 more authors. 2012-05-10 Head-to-head prenyl tranferases: anti-infective drug targets. [PMID:22486710 ]